format
inhibitori
antibodi
direct
coagul
factor
viii
fviii
sever
complic
treatment
hemophilia
patient
induct
antifviii
antibodi
celldepend
process
activ
fviiispecif
cell
depend
present
fviiideriv
peptid
mhc
class
ii
antigenpres
cell
previous
shown
fviiipuls
human
monocytederiv
dendrit
cell
present
peptid
sever
fviii
domain
studi
show
fviii
peptid
present
immatur
well
matur
dendrit
cell
immatur
dendrit
cell
half
fviiiload
mhc
class
ii
molecul
retain
within
cell
wherea
lpsmatur
dendrit
cell
major
mhc
class
iipeptid
complex
present
plasma
membran
timecours
studi
reveal
present
fviiideriv
peptid
optim
hour
matur
persist
least
hour
also
show
macrophag
abl
intern
fviii
effici
dendrit
cell
howev
fviii
present
mhc
class
ii
lower
effici
differ
epitop
compar
dendrit
cell
total
fviii
corepeptid
identifi
use
dc
deriv
differ
donor
five
hlapromiscu
fviii
peptid
region
found
present
least
donor
remain
peptid
core
region
fviii
present
dc
deriv
singl
peptid
two
three
donor
peptid
overal
find
show
broad
repertoir
fviii
peptid
present
hladr
citat
van
haren
sd
wroblewska
herczenik
e
kaijen
ph
ruminska
et
al
limit
promiscu
present
peptid
deriv
blood
coagul
factor
viii
plo
one
profession
antigenpres
cell
apc
dendrit
cell
dc
macrophag
abl
process
antigen
present
antigenderiv
peptid
context
major
histocompat
complex
mhc
molecul
present
intern
antigen
mhc
class
ii
dendrit
cell
requir
activ
helper
cell
subsequ
stimul
b
cell
produc
highaffin
antibodi
activ
cell
depend
recognit
specif
antigenderiv
peptid
context
appropri
mhc
ii
complex
also
requir
matur
dendrit
cell
lead
upregul
costimulatori
molecul
result
releas
specif
cytokin
determin
cell
differenti
variou
lineag
includ
regulatori
cell
cell
shown
contribut
fviiispecif
immun
respons
hemophilia
restimul
memori
cell
requir
upregul
costimulatori
molecul
also
occur
follow
present
fviii
peptid
macrophag
fviiispecif
b
cell
divers
cell
respons
depend
repertoir
cell
peptidebind
properti
mhc
molecul
present
apc
due
uniqu
properti
mhc
class
ii
allel
abil
present
differ
antigenderiv
peptid
allel
consid
associ
etiolog
autoimmun
disord
undesir
antibodi
respons
toward
protein
therapeut
moreov
sever
mhc
class
class
ii
allel
link
suscept
outcom
viral
infect
human
immunodefici
viru
type
hepat
c
viru
sarscoronaviru
identif
natur
present
peptid
clinic
relev
antigen
help
improv
vaccin
design
well
identif
pathogen
cell
involv
autoimmun
immun
respons
therapeut
protein
previous
report
feasibl
probe
repertoir
mhc
class
iipres
peptid
use
apc
puls
modelantigen
coagul
factor
viii
fviii
fviii
effici
intern
apc
vitro
well
vivo
hemophilia
patient
reduc
diminish
endogen
fviii
level
circul
replac
therapi
recombin
plasmaderiv
fviii
lead
format
fviiineutr
antibodi
commonli
refer
inhibitor
suggest
endocytosi
fviii
receptormedi
evid
fviii
effici
present
mhc
class
ii
process
fviii
apc
lead
present
variou
fviii
peptid
deriv
differ
domain
present
molecul
result
tcell
respons
patient
sever
hemophilia
polyclon
origin
direct
multipl
epitop
gener
peptid
either
promiscu
present
multipl
mhc
class
ii
molecul
present
uniqu
mhchaplotyp
restrict
studi
show
use
ovalbumin
fviii
sever
distinct
region
present
mhc
class
ii
also
show
fviiideriv
peptid
present
extend
period
time
fviiipuls
macrophag
dc
deriv
donor
present
differ
set
peptid
mhc
class
ii
analysi
panel
dc
deriv
multipl
donor
indic
limit
number
fviii
peptid
present
promiscu
manner
blood
drawn
hlatyp
healthi
anonym
volunt
inform
written
consent
accord
dutch
regul
follow
approv
sanquin
ethic
advisori
board
accord
declar
helsinki
volunt
take
sampl
know
project
specif
sampl
use
moreov
allow
annual
sampl
volum
frequenc
donat
establish
consult
sanquin
medic
secretari
addit
file
form
sign
blood
donor
attach
name
institut
review
board
specif
approv
studi
studi
follow
reagent
use
recombin
human
fviii
advat
kindli
provid
dr
bm
reipert
baxter
healthcar
corpor
vienna
austria
ovalbumin
hyglo
bernri
germani
microbead
mac
miltenyi
biotech
bergisch
gladbach
germani
bd
bioscienc
usa
mouseantiovalbumin
st
loui
usa
sanquin
reagent
amsterdam
netherland
cellgro
dc
serumfre
medium
mcsf
gmcsf
obtain
cellgenix
freiburg
germani
lp
obtain
sigmaaldrich
st
loui
usa
hybridoma
antihladr
obtain
atcc
wesel
germani
human
monocytederiv
dc
modc
macrophag
prepar
describ
previous
day
cultur
immatur
modc
macrophag
wash
replat
cellgro
medium
supplement
either
gmcsf
mcsf
concentr
cellsml
final
volum
ml
cell
incub
nm
fviii
ovalbumin
prior
induct
matur
immatur
modc
macrophag
matur
use
lp
h
presenc
human
serum
adher
matur
modc
detach
minut
incub
phosphat
buffer
salin
pb
contain
trisodiumcitr
wash
analysi
endocytosi
fviii
measur
describ
previous
briefli
fviii
endocytosi
perform
describ
endocytosi
cell
wash
cold
trisbuff
salin
tb
fix
paraformaldehyd
polysci
eppelheim
germani
cellassoci
intracellular
fviii
subsequ
measur
incub
cell
fitcconjug
antifviii
monoclon
antibodi
tb
saponin
human
serum
albumin
mean
fluoresc
intens
mfi
measur
use
lsr
ii
flow
cytomet
bd
bioscienc
uppsala
sweden
determin
phenotyp
cell
wash
pb
contain
bovin
serum
albumin
bsa
incub
antibodi
appropri
isotyp
control
dilut
bsa
min
cell
wash
twice
resuspend
bsa
cell
analyz
lsrii
flow
cytomet
beckton
dickinson
san
jose
usa
analyz
flowjo
softwar
version
tree
star
inc
ashland
usa
hladr
molecul
purifi
fviiitreat
matur
modc
macrophag
essenti
describ
previous
briefli
cell
pellet
lyse
use
mm
tri
ph
contain
igep
sigma
st
loui
usa
hladr
purifi
detergentsolubl
fraction
immunoaffin
chromatographi
use
antibodi
cnbr
sepharos
amersham
bioscienc
buckinghamshir
uk
presenc
proteas
inhibitor
complet
proteas
inhibitor
cocktail
tablet
tablet
per
ml
buffer
roch
diagnost
gmbh
mannheim
germani
wash
sepharos
time
mm
trishcl
ph
peptid
acid
elut
acet
acid
minut
elut
peptid
purifi
acet
acid
eluat
use
ziptip
millipor
billerica
usa
endocytosi
fviii
ovalbumin
cell
homogen
ste
buffer
sucros
mm
tri
mm
edta
contain
proteas
inhibitor
complet
proteas
inhibitor
cocktail
tablet
tablet
per
ml
buffer
roch
diagnost
gmbh
mannheim
germani
postnuclear
supernat
pn
obtain
centrifug
minut
load
linear
sucros
gradient
ml
densiti
gradient
obtain
centrifug
min
c
beckmann
optima
tm
xp
ultracentrifug
beckmann
instrument
palo
alto
ca
usa
fraction
ml
collect
high
low
sucros
densiti
subsequ
analyz
rel
mhc
class
ii
protein
content
nuncmaxisorp
plate
coat
anti
hladr
antibodi
carbon
buffer
mm
nahco
ph
overnight
fraction
subsequ
dilut
tween
bsa
ad
plate
mhc
class
ii
detect
hrplabel
antibodi
hlacont
fraction
measur
elisa
fraction
correspond
peak
hladr
content
pool
indic
nineti
percent
pool
analyz
hladr
present
peptid
remain
total
protein
content
tryptic
digest
sampl
boil
minut
break
organel
urea
ad
incub
rt
minut
next
urea
concentr
reduc
addit
mm
ammonium
bicarbon
buffer
subsequ
dithiothreitol
dtt
ad
final
concentr
mm
reduc
disulfid
bond
sampl
incub
minut
rt
next
iodoacetamid
ad
final
concentr
mm
sampl
incub
minut
rt
dark
final
sampl
digest
ngml
trypsin
overnight
peptid
prepar
mass
spectrometri
analysi
purif
use
ziptip
millipor
billerica
usa
identif
peptid
perform
essenti
describ
previous
briefli
elut
peptid
separ
use
reversedphas
column
flowrat
nlmin
gradient
vv
acetonitril
hac
elut
peptid
spray
directli
ltq
orbitrap
xl
mass
spectromet
thermo
fisher
scientif
bremen
germani
use
nanoelectrospray
sourc
spray
voltag
kv
collis
induc
dissoci
iontrap
normal
collis
energi
five
intens
precursor
ion
select
full
scan
orbitrap
mz
resolv
power
perform
obtain
high
mass
accuraci
ltq
orbitrap
calibr
monthli
basi
use
calibr
solut
consist
caffein
mrfa
ultramark
recommend
manufactur
peptid
identifi
use
sequest
search
algorithm
uniprotkb
nonredund
protein
databas
nonredund
entri
actual
search
util
proteom
discover
releas
version
softwar
thermo
scientif
bremen
germani
trypsindigest
protein
treat
iodoacetamid
search
perform
static
carbamidomethyl
modif
identif
peptid
perform
use
follow
filter
set
sequest
search
allow
mass
deviat
ppm
fragment
mass
toler
da
semiquantit
analysi
mhc
class
ii
bound
peptid
differenti
express
analysi
duplic
endocytosi
experi
analyz
releas
version
softwar
thermo
scientif
bremen
germani
softwar
use
compar
duplic
experi
subsequ
analyz
differ
peptid
abund
sampl
incub
differ
matur
condit
peptid
identif
criteria
use
describ
previous
shown
fviii
puls
monocytederiv
dendrit
cell
modc
effici
present
fviiideriv
peptid
mhc
class
ii
gain
insight
intracellular
fate
fviii
peptid
load
mhc
class
ii
molecul
subcellular
fraction
perform
use
sucrosedens
gradient
compar
amount
mhc
class
iibound
fviii
peptid
present
insid
cell
actual
present
plasma
membran
per
condit
million
modc
use
sucros
gradient
immatur
matur
dc
compris
distinct
peak
mhc
class
iicontain
fraction
pool
differ
pool
figur
file
tryptic
digest
subsequ
massspectrometri
analysi
figur
file
suggest
pool
correspond
highest
sucros
densiti
pool
contain
mostli
intracellular
protein
deriv
organel
mitochondria
mhc
class
ii
load
compart
vesicl
second
pool
enrich
plasma
membraneassoci
compon
top
fraction
pool
lowest
sucros
densiti
contain
materi
cell
organel
lyse
cell
disrupt
procedur
therefor
fraction
exclud
subsequ
analysi
hladr
first
intracellular
second
plasma
membran
pool
subsequ
purifi
analyz
presenc
fviii
peptid
immatur
dc
contain
signific
amount
fviii
peptid
process
load
hladr
figur
amount
complex
highli
similar
pool
contain
fviii
deriv
peptid
pool
contain
fviii
deriv
peptid
suggest
approxim
half
complex
alreadi
present
plasma
membran
immatur
dc
dc
matur
lp
present
total
fviii
peptid
major
local
plasma
membran
togeth
data
show
matur
dc
time
effici
present
fviii
peptid
compar
immatur
dc
also
address
persist
peptidemhc
class
ii
complex
matur
dc
figur
present
fviii
peptid
optim
hour
howev
approxim
half
fviii
peptid
remain
present
mhc
class
ii
least
hour
figur
later
time
point
includ
current
studi
sequenc
fviii
peptid
present
hour
correspond
peptid
present
earlier
time
point
figur
suggest
either
present
individu
peptid
persist
long
period
time
intracellular
storag
pool
continu
replenish
fviiimhc
class
ii
complex
plasma
membran
order
abl
directli
compar
antigenpres
capac
differ
cell
type
monocyt
healthi
donor
differenti
parallel
either
dc
macrophag
describ
materi
method
report
previous
macrophag
dc
abl
effici
intern
fviii
figur
suggest
vivo
macrophag
primarili
involv
endocytosi
fviii
therefor
investig
whether
human
macrophag
capabl
present
fviii
mhc
class
ii
similar
extent
human
modc
total
number
mhc
class
iipres
peptid
recov
macrophag
dendrit
cell
similar
figur
file
howev
less
fviii
peptid
recov
fviiipuls
macrophag
compar
modc
figur
figur
file
macrophag
present
less
fviii
peptid
also
differ
smaller
repertoir
fviii
peptid
compar
dc
moreov
analysi
averag
intens
fviii
peptid
indic
figur
persist
present
fviii
peptid
matur
dc
endocytosi
fviii
immatur
dc
follow
matur
lp
either
bound
peptid
purifi
analyz
mass
spectrometri
bar
diagram
indic
total
amount
peptid
identifi
condit
well
amount
fviii
peptid
core
peptid
core
peptid
defin
set
peptid
overlap
sequenc
harbor
mhc
class
ii
bind
motif
heterogen
peptid
length
due
aminotermin
andor
carboxytermin
trim
present
peptid
present
fviii
peptid
compar
immatur
dc
lpsmatur
dc
cell
homogen
pn
fraction
sucros
densitygradi
fraction
sucros
gradient
analyz
elisa
mhc
class
ii
molecul
divid
plasma
membran
pool
pm
intracellular
pool
ic
see
figur
file
peptid
purifi
pool
use
analyz
mass
spectrometri
left
yaxi
total
number
fviii
peptid
recov
mhc
class
ii
indic
peptid
right
yaxi
number
core
peptid
core
peptid
indic
core
peptid
defin
set
peptid
overlap
sequenc
harbor
mhc
class
ii
bind
motif
heterogen
peptid
length
due
aminotermin
andor
carboxytermin
trim
present
peptid
doi
major
present
effici
dc
compar
macrophag
figur
file
previou
paragraph
document
cellular
requir
present
fviii
deriv
peptid
mhc
class
ii
establish
potenti
relev
experiment
system
antigen
explor
whether
puls
modc
differ
commonli
use
solubl
antigen
ovalbumin
ova
result
present
ovalbuminderiv
peptid
modc
figur
b
ovapuls
dc
lyse
cell
lysat
immunoprecipit
use
either
antimhc
class
ii
antibodi
isotyp
control
antibodi
figur
peptid
fivefold
higher
rel
abund
mhc
class
ii
pulldown
consid
true
mhc
class
iipres
peptid
peptid
repres
trim
variant
core
peptid
sequenc
deriv
ova
identifi
figur
one
ova
peptid
consid
true
mhc
class
iipres
peptid
indic
red
figur
part
peptid
identifi
cover
welldocu
region
compris
epitop
recogn
murin
ovalbumin
specif
otii
cell
collect
result
show
similarli
fviii
modc
present
peptid
deriv
multipl
region
wide
use
model
antigen
ovalbumin
previous
report
modc
deriv
differ
donor
divers
hladr
haplotyp
present
differ
region
fviii
extend
find
analyz
fviii
peptid
repertoir
present
modc
deriv
addit
donor
similar
fashion
describ
ovalbumin
figur
isotypecontrol
immunoprecipit
routin
perform
fviiipuls
modc
distinguish
true
hladrbind
peptid
aspecif
precipit
peptid
describ
previous
control
experi
result
identif
fviii
peptid
length
exceed
amino
acid
contain
ident
core
sequenc
peptid
exclud
subsequ
analysi
result
donor
studi
assembl
figur
corepeptid
sequenc
deriv
fviii
peptid
identifi
donor
depict
three
promiscu
peptid
present
modc
deriv
least
donor
figur
corepeptid
sequenc
frnqasrpi
domain
present
donor
domainderiv
corepeptid
sequenc
liifknqa
domainderiv
corepeptid
flisssqdg
find
indic
repertoir
fviii
peptid
present
mhc
class
ii
exclus
shape
polymorph
within
hladr
studi
show
previous
establish
method
peptid
present
hladr
use
studi
contribut
variou
cellular
process
repertoir
antigenspecif
peptid
present
mhc
class
ii
result
indic
vitro
gener
antigenpres
cell
type
use
studi
physiolog
aspect
present
model
antigen
fviii
ovalbumin
mhc
class
ii
total
differ
fviii
corepeptid
identifi
previou
studi
import
note
tcell
reactiv
toward
major
peptid
shown
clinic
experiment
set
six
fviii
region
identifi
studi
previou
work
reactiv
cell
identifi
either
hemophilia
patient
hemophilia
mice
addit
anoth
six
peptid
describ
paper
endocytosi
differ
concentr
fviii
either
modc
macrophag
measur
flow
cytometri
highest
mfi
measur
dc
set
data
point
rel
mfi
express
mfi
b
cell
lysat
fviiitreat
modc
macrophag
use
purifi
peptid
use
antimhc
class
ii
antibodi
graph
show
quantif
individu
mhc
class
iibound
fviii
peptid
c
schemat
represent
fviii
core
peptid
present
dendrit
cell
macrophag
gener
monocyt
donor
f
doi
figur
present
ova
peptid
modc
ovalbuminderiv
peptid
identifi
mass
spectrometri
purif
lysat
ovalbuminpuls
cell
either
antihladr
antibodi
isotyp
antibodi
siev
use
compar
intens
individu
peptid
averag
intens
identifi
peptid
plot
diagon
line
indic
equal
intens
condit
dot
line
indic
differ
intens
peptid
cluster
fold
chang
higher
consid
true
mhc
class
iibound
peptid
peptid
sequenc
msm
depict
b
ovalbumin
peptid
identifi
experi
list
sequenc
charg
masscharg
ratio
mz
retent
time
rt
xcorr
valu
hladrisotyp
ratio
ratio
intens
peptid
detect
antimhc
class
ii
pulldown
intens
detect
pulldown
isotyp
control
antibodi
peptid
exclud
due
ratio
lower
mark
red
doi
recent
identifi
epitop
novel
human
transgen
mous
model
hemophilia
comparison
peptiderepertoir
present
donor
share
ident
close
relat
allel
suggest
limit
overlap
although
limit
number
donor
make
difficult
draw
strong
conclus
regard
hlarestrict
peptid
present
result
suggest
addit
donorspecif
factor
could
also
modul
repertoir
present
fviii
peptid
degrad
intern
antigen
present
mhc
class
ii
depend
proteolyt
activ
varieti
proteas
cathepsin
b
e
g
l
asparaginespecif
endopeptidas
aep
express
andor
activ
enzym
express
fviiiintern
receptor
differ
donor
monocytederiv
dc
macrophag
readili
intern
fviii
dc
notabl
effici
present
fviii
peptid
hladr
studi
macrophag
present
limit
number
fviii
peptid
differ
present
dc
deriv
donor
observ
underscor
cellular
context
contribut
effici
divers
fviii
peptid
present
mhc
class
ii
studi
show
immatur
modc
abl
present
antigen
peptid
mhc
class
ii
albeit
less
effici
lpsmatur
modc
fviii
peptid
load
hladr
matur
modc
present
plasma
membran
contrast
hladr
molecul
load
fviii
peptid
immatur
modc
resid
insid
cell
plasma
membran
indic
immatur
dc
less
effici
present
fviiideriv
peptid
cell
howev
complet
incap
immatur
modc
express
low
level
costimulatori
molecul
make
suitabl
induc
immun
toler
toward
fviii
concept
alreadi
verifi
previou
studi
treatment
hemophil
mice
fviiipuls
immatur
dc
shown
induc
expans
regulatori
cell
inhibit
fviiispecif
immun
respons
present
fviii
peptid
hladr
peak
hour
matur
level
half
amount
peptid
matur
take
place
hour
dc
like
abl
retain
capac
fviii
present
matur
induc
decreas
turnov
mhc
class
ii
molecul
anoth
explan
could
fviii
peptid
continu
replenish
intracellular
depot
previous
shown
ovalbumin
immatur
dc
also
abl
present
antigen
peptid
mhc
class
ii
turnov
complex
much
higher
make
immatur
dc
less
effect
present
antigen
cell
previous
shown
repertoir
fviii
peptid
present
surfac
apc
strongli
influenc
allel
donor
current
data
provid
addit
evid
present
limit
number
fviii
peptid
bind
multipl
molecul
major
fviiideriv
peptid
identifi
studi
present
modc
deriv
singl
donor
figur
peptid
present
modc
deriv
differ
donor
figur
suggest
individu
present
set
privat
fviii
peptid
mechan
underli
divers
present
peptid
current
unclear
differ
observ
dc
macrophag
indic
factor
regul
proteolyt
activ
within
apc
may
also
shape
repertoir
fviii
peptid
sever
cytokin
abl
induc
chang
present
antigen
chang
express
activ
intracellular
proteas
cytokin
known
impact
risk
inhibitor
format
hemophilia
patient
would
interest
studi
effect
cytokin
present
fviii
mhc
class
ii
note
clinic
relev
find
crucial
depend
specif
hierarchi
fviiispecif
cell
present
hemophilia
patient
limit
data
avail
modif
put
tcell
epitop
fviii
molecul
propos
result
hladepend
reduct
fviii
immunogen
current
find
may
therefor
assist
search
fviiispecif
cell
hemophilia
patient
could
therebi
contribut
develop
fviii
variant
reduc
immunogen
file
figur
subcellular
fraction
immatur
matur
modc
sucros
densitygradi
present
fviii
compar
immatur
dc
lpsmatur
dc
cell
homogen
pn
fraction
sucros
densitygradi
fraction
sucros
gradient
analyz
elisa
mhc
class
ii
molecul
divid
pool
per
sampl
indic
b
peptid
pool
identifi
mass
spectrometri
tryptic
digest
identifi
protein
annot
base
subcellular
local
function
use
databas
annot
visual
integr
discoveri
david
bioinformat
resourc
c
access
number
protein
identifi
differ
subcellular
fraction
figur
present
fviii
peptid
modc
macrophag
intens
plot
show
reproduc
detect
peptid
ion
across
duplic
analys
total
cell
lysat
fviiitreat
modc
macrophag
deriv
donor
use
purifi
peptid
use
antimhc
class
ii
antibodi
siev
use
compar
intens
individu
peptid
averag
intens
identifi
peptid
plot
diagon
line
indic
equal
intens
condit
dot
line
indic
differ
intens
b
fviii
peptid
identifi
experi
list
sequenc
averag
intens
cell
lysat
macrophag
dendrit
cell
intens
ratio
two
condit
pdf
conceiv
design
experi
sdvh
aw
eh
atb
abm
jv
perform
experi
sdvh
ar
eh
abm
phk
analyz
data
sdvh
aw
abm
jv
wrote
manuscript
sdvh
aw
jv
provid
expertis
cultur
analyz
phenotyp
characterist
dendrit
cell
atb
